Transcription by RNA polymerase III (Pol III) is an essential cellular process, and mutations in 13 Pol III can cause neurodegenerative disease in humans. However, in contrast to Pol II 14 transcription, which has been extensively studied, the knowledge of how Pol III is regulated is 15 very limited. We report here that in budding yeast, Saccharomyces cerevisiae, Pol III is 16 negatively regulated by the Small Ubiquitin-like MOdifier (SUMO), an essential post-17 translational modification pathway. Besides sumoylation, Pol III is also targeted by 18 ubiquitylation and the Cdc48/p97 segregase, the three of which likely act in a sequential manner 19 and eventually lead to proteasomal degradation of Pol III subunits, thereby repressing Pol III 20 transcription. This study not only uncovered a regulatory mechanism for Pol III, but also 21 suggests that the SUMO and ubiquitin modification pathways and the Cdc48/p97 segregase can 22 be potential therapeutic targets for Pol III-related human diseases. 23 24 Kassavetis, 2001). In budding yeast, Saccharomyces cerevisiae, TFIIIB is composed of Brf1, 32 Bdp1, and TBP. TFIIIC is composed of Tfc1, Tfc3, Tfc4, Tfc6, Tfc7, and Tfc8. For 5S rRNA 33 transcription, all three basal transcription factors are required, whereas tRNA transcription only 34 requires TFIIIB and TFIIIC. As important as it is for normal cell physiology, Pol III plays critical 35 roles in pathological processes, such as virus infection (Chiu, Macmillan, & Chen, 2009) and 36 tumorigenesis (White, 2004). In addition, Pol III mutations were recently found to cause 37 neurodegenerative diseases in humans. Mutations that cause hypomyelinating leukodystrophy 38 with 4H syndrome occur predominantly in the largest two subunits of Pol III, POLR3A and 39
INTRODUCTION
Eukaryotes have three conserved DNA-directed RNA polymerases (RNA Pols) (Roeder & 26 Rutter, 1969 , 1970 Weinmann & Roeder, 1974; Zylber & Penman, 1971) , where Pol I 27 transcribes most of the rRNAs, Pol II transcribes mRNA, and Pol III transcribes tRNA, 5S 28 rRNA, as well as some non-coding RNAs, such as the U6 snRNA involved in mRNA splicing. 29 The Pol III machinery includes the polymerase itself (composed of 17 subunits), as well as basal 30 transcription factors TFIIIA, the TFIIIB complex, and the TFIIIC complex (Geiduschek & Maf1 (Moir et al., 2006; Oficjalska-Pham et al., 2006; Roberts, Wilson, Huff, Stewart, & Cairns, 48 2006) and the Rpc53 subunit of Pol III (Lee, Moir, McIntosh, & Willis, 2012) . Maf1 is a robust 49 Pol III repressor (Boguta, 2013; Moir & Willis, 2013) . Upon stress, Maf1 is dephosphorylated 50 and translocated into the nucleus, where it binds Pol III and blocks its interaction with TFIIIB III transcription machinery, 116 including the largest two 117 subunits of Pol III (Rpc160 and   118 Rpc128), a TFIIIB subunit 119 (Brf1), and two TFIIIC subunits (Tfc1 and Tfc6). To confirm the screen results, the identified 120 mutations were introduced into wild type cells, and subsequently crossed with a strain lacking a 121 major SUMO E3 ligase, Siz1 (siz1). For example, introduction of the M809I mutation in 122 Rpc160 ( Figure 1A ) and the A704T mutation in Rpc128 ( Figure 1B) caused severe growth 123 defects, while siz1fully rescued rpc160-M809I and partially rescued rpc128-A704T, as 124 Table 1 . Summary of mutations rescued by SMT3-Q56K.
Figure 1. Disrupting sumoylation rescues Pol III mutations. (A)
Tetrad analysis of a cross between rpc160-M809I and siz1. Tetrads were dissected on YPD, then incubated at 30°C for four days. The offspring of one representative tetrad was shown with genotypes labeled. (B) Similar tetrad analysis for rpc128-A704T and siz1. (C) Similar tetrad analysis for rpc160-M809I and siz2. (D) 2 g of RNA extracted from the indicated strains was run on a 2.8% agarose gel containing ethidium bromide, then visualized with UV. (E) RNA from (C) was reverse transcribed into cDNA, followed by realtime PCR analysis. GAPDH transcripts were used as loading control. Data are mean ± standard deviation calculated from 6 data points (two biological replicates and three technical replicates), presented as relative amount compared to wild type. The intron-containing pre-mature tRNA (pre-tL(CAA)A) is short-lived, so its abundance reflects the Pol III transcriptional activity. growth of a strain in which the only RPC160 gene was under the GAL1 promoter in glucose, the 145 resultant slow growth phenotype was partially rescued by siz1 ( Figure S3B ). We also tested 146 whether human Pol III mutations that cause neuronal diseases, which were introduced into yeast 147 Rpc160, Rpc128, and Brf1 at corresponding positions based on sequence homology, could be 148 rescued when sumoylation was compromised. Among the seventeen Rpc160 mutations tested for 149 growth under normal conditions and at elevated temperature (37°C) (Table S3 ), two single 150 (Q608K and E1329K) and two double mutations (D384N, N789I and Q608K, G1308S) caused 151 growth defects, which could all be rescued by siz1, except for E1329K ( Figure S3C) . For 152 Rpc128, only one of the five single mutations (L1027P) showed slower growth, which was 153 rescued by siz1( Figure S3D) . All rpc128 double mutations were lethal, and not rescued by 154 siz1 (Table S3 ). For the four brf1 single mutations, three showed growth defects, two of which 155 were rescued by siz1 ( Figure S3E) . These results confirmed the roles of SUMO in Pol III 156 transcription, suggesting that SUMO can repress Pol III but the effect is most obvious when Pol The rpa190 rpb1 or rpc160 strain carries a URA3 plasmid carrying wild type RPA190, RPB1, and RPC160 gene, respectively, in order to maintain viability. These strains were then transformed with LEU2 plasmids carrying the indicated wild type or mutant alleles, and selected on synthetic media lacking leucine (SC-L). Transformants were spotted in 5-fold serial dilutions onto a 5FOA plate to assess the growth phenotype of the mutant allele, as the original URA3 plasmids were shuffled out of the cell in the presence of 5FOA. (B-D) Tetrad analysis between rpc160-M809I (shown as rpc160) and kns1, mck1, and maf1. (E) Tetrad analysis between rpc160-M809I siz1 and maf1. (F) The indicated strains from the cross in (E) were plated in 5-fold dilutions onto YPD (glucose) or YPG (glycerol) plates and incubated at 30°C or 37°C as indicated.
Rpc53 and Rpc37 form a subcomplex in the Pol III holoenzyme (Hoffmann et al., 2015; 197 Kassavetis, Prakash, & Shim, 2010; Landrieux et al., 2006) . Identifying both of them suggests 198 that they are either tightly associated with a sumoylated protein or are sumoylated themselves. 199 Indeed, Rpc53 was extensively sumoylated in vivo, and this was largely dependent on Siz1 but 200 not Siz2 ( Figure 3C) , correlating with the fact that siz2 did not rescue the rpc160 mutant 201 growth defect ( Figure 1C ). Rpc53 was sumoylated more extensively in rpc160 mutant cells 202 ( Figure 3D ), suggesting that it may serve as a better SUMO substrate when Pol III is defective. 203 The major sumoylation sites were mapped to K51, K115, and K236, by showing that mutating 204 all three of them to arginines (K51, 115, 236R, or rpc53-3KR) abolished the majority of 205 sumoylation, and no modification was detected when the N-terminal 274 amino acids of Rpc53 206 were deleted (2-275) ( Figure 3E) . Importantly, rpc53-3KR rescued the rpc128-A704T growth 207 defect ( Figure 3F ), whereas SUMO fusion to the N-terminus of Rpc53 (Su-rpc53-3KR), which 208 mimics constitutive sumoylation, abolished the rescue effect of Rpc53-3KR. The SUMO-Rpc53-209 3KR fusion protein was expressed and functional, as it fully complemented the growth defect of 210 rpc53 null ( Figure 3G) . The rescue by rpc53-3KR was partial, suggesting additional 211 modification sites in Rpc53 or other relevant SUMO substrates exist. Nevertheless, these results Total protein extracted from the indicated strains was subjected to anti-Flag IP to purify Flag-tagged Rpc160 Pol III complexes and associated proteins. Precipitated proteins were eluted with Flag peptide, followed by SDS-PAGE and immunoblot analysis with an anti-Flag or anti-SUMO antibody. (B) The eluant from (A) was subjected to anti-GFP IP using GFP-Trap beads to isolate the sumoylated species from Pol III. The beads were subsequently washed with PBS containing 8M urea and 1% SDS to remove Rpc160-associated unmodified proteins, then incubated with 2x Laemmli's buffer at 100°C to elute sumoylated proteins. The success of the IP was confirmed by anti-SUMO immunoblot. The purified materials were subjected to tryptic digestion and analyzed by mass-spectrometry. (C) Flag-tagged Rpc53 was IP-ed from the indicated strains using anti-Flag beads, and detected by an anti-Flag antibody (bottom). Sumoylated Rpc53 (Su-Rpc53) was detected by anti-SUMO antibody (top). An untagged RPC53 strain was used as a negative control. (D) Similar experiment as in (C) showing Rpc53 sumoylation in wild type RPC160 cells versus rpc160-M809I mutant cells. (E) Mapping Rpc53 sumoylation sites by mutagenesis analysis. CEN plasmids carrying wild type or mutant Flag-tagged RPC53 were co-transformed with a 2 SMT3 plasmid into a wild type yeast strain. Rpc53-Flag proteins were purified with anti-Flag IP, followed by SDS-PAGE and immunoblot analysis with anti-Flag (bottom) or anti-SUMO antibody (top). (F) An rpc128-A704T strain carrying a URA3 RPC128 plasmid was transformed with LEU2-based RPC128 or RPC53 plasmids, then grown on 5FOA medium, which forces the cells to lose the URA3 RPC128 plasmid. rpc53-3KR (K51,115,236R) rescued the growth of rpc128-A704T, whereas N-terminal SUMO fusion (Su-rpc53-3KR) abolished the rescue effect. The rescue effect is dominant because all the cells in this experiment contain wild type RPC53 in the genome. (G) Similar plasmid shuffle experiment as in Figure 2A . The LEU2 plasmids carrying the indicated RPC53 alleles were transformed into an rpc53 strain containing a URA3 RPC53 plasmid. The transformants were then plated onto a 5FOA plate to lose the URA3 RPC53 plasmid, and the results showed that the N-terminally SUMO-fused Rpc53 protein (Su-rpc53-3KR) fully supports cell viability.
Figure 4. Pol III is repressed by ubiquitylation and p97/Cdc48. (A-C)
The indicated rpc160 mutant strains were crossed with slx5, slx8, or ubc4 strain, respectively, followed by tetrad analysis. The cross between slx8 and rpc160-G1297D was shown, because slx8 caused obvious growth defect by itself, so the rescue effect was more obvious on rpc160-G1297D which is a sicker mutant than rpc160-M809I. (D) Yeast two-hybrid interactions between Slx5 and Rpc53. SLX5 and RPC53 were cloned into a 2 LEU2 Gal4 activation-domain (AD) vector and a 2 TRP1 DNA-binding domain (BD) vector, respectively, and co-transformed into yeast strain PJ69-4A. Transformants were selected on synthetic media lacking leucine and tryptophan (SC-LW), then patched and replica plated to selective media lacking histidine to test for interactions. The histidine-lacking media was supplement with 3-aminotriazole (SC-LWH+3AT) for a more stringent phenotype. (E) LEU2 plasmids carrying HA-tagged wild type or SIM-defective SLX5 (HA-slx5-sim) were transformed into an rpc160-G1297D slx5 strain containing a URA3 RPC160 plasmid. Transformants were selected on SC-L then spotted onto an SC-L+5FOA plate to lose wild type RPC160. HA-SLX5 complemented slx5 so the cells became sicker compared to the empty vector control transformants, while HA-slx5-sim did not complement, indicating that the SIMs are essential for the function of SLX5 in this assay. The lost Slx5 function by the SIM mutations was not caused by insufficient proteins, since there were comparable levels of Slx5 proteins, as determined by an anti-HA immunoblot on total cell lysates (right, top panel). G6PDH served as a loading control (right, bottom panel). (F-I) Tetrad analysis between rpc160- M809I and cdc48-3, cdc48-sim, ufd1-sim, and ufd1-1, respectively. Figure 4I ), suggesting Ufd1 is not the cofactor used by Cdc48 in this case.
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Pol III repression is partially mediated by ubiquitylation of Rpc160. 243 It is conceivable that STUbL-mediated ubiquitylation represses Pol III by modifying components 244 of the transcription machinery, including subunits of Pol III itself. We noticed that the mutant 245 Rpc160-M809I proteins are less stable than wild type Rpc160, as determined by a 246 cycloheximide-chase experiment ( Figure 5A ), suggesting the mutant Rpc160 proteins are 247 degraded and therefore Rpc160 is likely to be ubiquitylated. Rpc160 can be ubiquitylated at 248 1240, K1242, K1249, K1273, and K1432, as determined by a previous proteomic study (Swaney 249 et al., 2013) . When the three clustered lysines were mutated to arginines (K1240, 1242, 1249R or 250 3KR), Rpc160-M809I proteins became more stable ( Figure 5A ) and the phenotypes of rpc160-251 M809I, including slow growth ( Figure 5B ) and reduced tRNA levels ( Figure 5C ), were partially plasmids expressing HA-tagged wild type or mutant Rpc160, as indicated, were transformed into a wild type strain, and their stabilities were assayed during a cycloheximide (CHX) chase time course. Rpc160 was detected by an anti-HA antibody, and G6PDH was used as a loading control. Quantification of the bands was shown below the immunoblot. (B) Tetrad analysis of the diploid strains, RPC160+/rpc160-M809I (top) and RPC160+/rpc160-M809I-3KR (bottom). Tetrads from these two diploids were dissected and plated on the same YPD plate at the same time, in order to compare the growth of rpc160-M809I and rpc160-M809I-3KR cells. The growth of three dissected tetrads were shown. The large colonies are wild type RPC160 cells, and the small colonies are rpc160-M809I (top) or rpc160-M809I-3KR (bottom) cells. The rpc160-M809I-3KR cells grew slightly faster than the rpc160-M809I cells. (C) Left: 2 g of RNA extracted from the indicated strains was run on a 2.8% agarose gel containing ethidium bromide, then visualized with UV. Two colonies were picked for each strain. Right: RNA from left was reverse transcribed into cDNA, followed by real-time PCR analysis, as described in Figure 2E . GAPDH transcripts were used as loading control. (D) Similar tetrad analysis as in (B) of the diploid strains, RPC160+/rpc160-G1297D (top) and RPC160+/rpc160-G1297D-3KR (bottom). Large colonies are wild type RPC160 cells, while the missing colonies (top) are rpc160-G1297D cells, and the small colonies (bottom) are rpc160-G1297D-3KR cells. (E) An rpc128-A704T strain was crossed with an rpc160-3KR strain, followed by tetrad analysis. (F) A CEN URA3 rpc160-M809I-HA plasmid was transformed into the indicated strains, and the stabilities of the Rpc160-M809I-HA proteins were determined by CHX chase time course, as described in (A). (G) A CEN URA3 rpc160-M809I-HA plasmid was transformed into a wild type strain, and protein stabilities were determined by CHX chase experiment in the presence of DMSO or MG132.
Interestingly, the 3KR mutation, when introduced into wild type Rpc160 proteins, could rescue 6A). Furthermore, the SAP domain was also required for Siz1 to sumoylate Rpc53 ( Figure 6D ) 276 and to inhibit the growth of the rpc160 mutant cells ( Figure 6E ). Besides Siz1, the STUbL 277 subunit Slx8 also contains a DNA-binding activity, which was mapped to the N-terminal 163 278 amino acids (Yang, Mullen, & Brill, 2006) . Similarly, Slx8 requires this DNA-binding domain to 279 inhibit the growth of the rpc160 mutant cells ( Figure 6F ). However, the DNA-binding domain is 280 not required for Slx8 to associated with chromatin (data not shown), as previously reported 281 (Yang et al., 2006) . Therefore, the targeting of Pol III by SUMO and ubiquitin is likely to occur 282 on the chromatin, and require a physical interaction between DNA and the modifying enzymes.
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Figure 6. DNA is involved in Pol III repression. (A-C)
Chromatin IP of Siz1-Flag, HA-Slx5, and Cdc48-3-Flag, respectively, using anti-Flag or anti-HA beads depending on the tag. An untagged strain was used as negative control. Chromatin association was determined by real-time PCR of the indicated genomic loci, using the percent of input method. Data are mean ± standard deviation calculated from 6 data points (two biological replicates and three technical replicates). (D) Flag-tagged Rpc53 proteins were purified from the indicated wild type or siz1 mutant strains, using anti-Flag beads, followed by SDS-PAGE and immunoblotting using an anti-SUMO antibody. Rpc53 was detected by an anti-Flag antibody, and Siz1 was detected by an anti-Myc antibody. Either truncation (SAP) or point mutation (SAP*) of the SAP domain resulted in loss of Rpc53 sumoylation. (E) Left: LEU2 plasmids carrying wild type or mutant SIZ1 alleles were transformed into an rpc160-M809I siz1 strain containing a URA3 RPC160 plasmid. Transformants were selected on SC-L plate, then spotted in 5fold dilution onto a SC-L+5FOA plate. Wild type SIZ1 complemented siz1 so the cells became sick on SC-L+5FOA plate, while the SAP mutants did not complement. Right: Comparable amounts of wild type and mutant Siz1 proteins were determined by anti-Flag immunoblotting on whole cell lysate, using G6PDH as loading control. (F) Similar plasmid shuffle experiment as in (E). LEU2 plasmids carrying HA-tagged wild type SLX8 or slx8N (2-163) were transformed into an rpc160-G1297D slx8 strain containing a URA3 RPC160 plasmid. Wild type SLX8 complemented slx8, while slx8N did not. Comparable amounts of Slx8 proteins were determined by an anti-HA immunoblot. (G) Model of Pol III regulation by SUMO, ubiquitin, and Cdc48. A stable interaction between chromatin and the SAP domain of Siz1 stimulates its activity to modify Rpc53 with SUMO (S). Rpc53 sumoylation triggers ubiquitin (U) modification of Rpc160 and potentially other proteins by the Slx5-Slx8 complex, which also required the interaction between chromatin and the DNA-binding domain (DBD) of Slx8. Ubiquitylation subsequently activates Cdc48 to disassemble the Pol III complex, facilitating degradation of Pol III subunits by the proteasome. (Psakhye & Jentsch, 2012) . In such cases, sumoylation on multiple proteins would need to be 296 abolished simultaneously to reveal a phenotype, making genetic analysis of SUMO function 297 more difficult. To address this challenge, we devised, a phenotype-based genetic screen that 298 selects for point mutations in yeast whose growth is rescued only when sumoylation is 299 compromised, allowing identification of proteins where sumoylation has a functional 300 consequence that can then be studied. 301 302 SUMO-ubiquitin-Cdc48 is a new regulatory pathway for Pol III 303 We used a yeast genetic approach to uncover a functional relationship between Pol III and 304 SUMO, demonstrating that genetics is a powerful tool to study sumoylation, complementary to 305 the biochemical approach. Performing the same type of screen under different conditions is 306 likely to yield more functional SUMO targets in the cell, and the same principle can be 307 potentially extended to study other posttranslational forms. Our findings support a model where 308 SUMO, ubiquitin, and Cdc48 act in a linear pathway to repress Pol III transcription ( Figure 6G) . 309 In this model, a defective/stalled chromatin-associated Pol III complex on a tRNA gene is first 310 recognized by the chromatin-associated Siz1 E3 SUMO ligase and sumoylated on the Rpc53 The SUMO-ubiquitin-Cdc48 pathway may serve as a quality control mechanism for Pol III 324 In the particular case reported here, the SUMO-ubiquitin-Cdc48 pathway seems to preferentially 325 target defective Pol III, based on the results that siz1 only has an obvious effect when the 326 function of Pol III is impaired, that more Siz1, Slx5, and Cdc48 proteins are associated with 327 tRNA genes, and that Rpc53 is more extensively sumoylated in mutant rpc160 cells. The 328 question is, what Pol III defect is being recognized by the pathway? Since mutations in the Pol 329 III initiation factors Brf1, Tfc1, and Tfc6 can also be rescued by disrupting sumoylation, it is 330 likely that a defect in transcription initiation is being recognized. This is supported by the result 331 that siz1 rescued an initiation-defective mutant, rpc31-236. In Rpc160, the mutations T379I will allow STUbL to stably bind to DNA and activate its ligase activity. Therefore, Rpc53 368 sumoylation itself will not be sufficient to trigger ubiquitylation to inhibit Pol III. This is 369 supported by the finding that SUMO-fused Rpc53 did not affect cellular growth (Figure 3G) , 370 even though the N-terminal SUMO fusion could functionally replace sumoylation on the natural 371 modification sites (K51, K115, and K236) ( Figure 3F) . These results also suggest that 372 sumoylation may not activate Cdc48 directly, but rather indirectly through ubiquitylation. The SUMO-ubiquitin-Cdc48 pathway is a potential target for Pol III-related human 385 diseases. 386 Given the fact that Pol III, sumoylation, ubiquitylation, and Cdc48 are all conserved from yeast 387 to humans, this new Pol III regulatory mechanism is likely to be conserved as well. In fact, 388 proteomic studies of sumoylation in mammalian cells have identified sumoylated proteins in Pol 389 III, including four Pol III-specific subunits and two subunits shared by Pol I and/or Pol II ( , 2015; Saitsu et al., 2011; Shimojima et al., 2014; Synofzik et al., 2013; Terao et al., 2012; 399 Tetreault et al., 2011; Thiffault et al., 2015) . We showed, interestingly, that the phenotypes 400 caused by a subset of these Pol III disease mutations, when introduced into yeast cells, were 401 rescued when sumoylation was disrupted ( Figure S3 and Table S3 ). In addition, the fibroblasts 402 derived from a patient carrying Pol III mutations exhibited reduced levels of tRNA (data not 403 shown), as is the case in yeast. It is thus intriguing to speculate that sumoylation, ubiquitylation, 404 and Cdc48 segregase can all be potential therapeutic targets for the neurodegenerative disease 405 caused by Pol III mutations. The next step is to determine if this regulatory mechanism is 406 conserved in humans, by testing it in cultured mammalian cells and mouse model systems. We 407 have shown that the yeast growth assay is a convenient tool to determine which 408 neurodegenerative disease mutations are likely to cause a phenotype and therefore, which should be chosen to create cell lines and mouse models. It is possible to differentiate iPSC lines into 410 myelinating oligodendrocytes in vitro (Kerman et al., 2015) , and the oligodendrocytes from Pol 411 III patients are expected to display a myelination defect. Alternatively, a cell line can be made to 412 carry a lethal mutation in one copy of a Pol III subunit gene while leaving the wild type copy The Saccharomyces cerevisiae strains and plasmids used in this study are listed in Table S5 423 and Table S6 , respectively. All media used, including rich YPD medium (yeast extract-peptone-424 dextrose), sucrose medium (yeast extract-peptone-Suc), synthetic complete (SC) drop-out 425 medium (for example, SC-U), SC-galactose medium and sporulation medium, were made as 426 described previously (Rose, 1990) . SC-L+5FOA plates were made as standard SC drop-out 427 medium, but using 2 g of SC-UL drop-out mix, plus 50 mg of uracil, and 1 g of 5FOA per 1 liter 428 of total volume. For a more stringent yeast two-hybrid interaction signal, 24 mol of 3-429 aminotriazole (3AT) was spread onto a 10 cm SC-LWH plate. Standard genetic methods for 430 mating, sporulation, transformation, and tetrad analysis were used throughout this study. In the 431 tetrad analysis experiments, the mutant haploid rpc160 or rpc128 strains contain a URA3 vector 432 carrying wild type copy of gene, in order to maintain the strains. The URA3 plasmids were lost 433 from the diploid cells on 5FOA media after mating and before sporulation. The similar strategy 434 was used in the plasmid shuffle experiments, for example, in Figure 2A , where the starting 435 rpc160 strain contains a URA3 RPC160 plasmid. Upon transformation with LEU2 plasmids 436 carrying rpc160 mutant alleles, the transformants were plated onto 5FOA-containing media to 437 lose the URA3 RPC160 plasmid. Growth on 5FOA media therefore reflects the growth 438 phenotype of the rpc160 mutants present on the LEU2 plasmids.
The mutations in slx5-sim are: 24VILI -VAAA, 93ITII -ATAA, 116YVDL -YAAA, and 440 155LTIV -ATAA. The siz1SAP and siz1-SAP* mutations were made as previously described 441 (Parker et al., 2008) . 442 443 Design of the reverse suppressor screen of SMT3-Q56K. 444 The starting strain is ZOY261 (ade2 ade3 ura3 leu2 trp1 can1::FUR1::natMX4) carrying 445 two plasmids, pZW321 (CEN URA3 ADE3 SMT3-Q56K) and pAK12-1 (CEN TRP1 ade3-pink) 446 (Koren, Ben-Aroya, Steinlauf, & Kupiec, 2003) , and grown on SC-Leu-Trp in order to keep the 447 plasmids. Wild type yeast cells are white, while ade2 mutant is red. ade3 mutation suppresses 448 ade2, so that ade2 ade3 double mutant is white. Both ade2 and ade3 are recessive, so in the 449 presence of pZW321, ZOY261 colonies are red. The starting strain (ZOY261 + pZW321 + 450 pAK12-1), if grown on YPD, does not need pZW321 for viability, so the cells will lose the 451 plasmid during cell proliferation, eventually forming colonies with red and white sectors. The 452 screen looks for mutations that cause sickness or lethality, but can be suppressed / rescued by 453 SMT3-Q56K on pZW321. These mutants will appear as uniformly red colonies, because they 454 always need to keep pZW321 for viability. They will also be sensitive to 5FOA, because 5FOA 455 counter-selects against URA3 on pZW321. 456 To perform the screen, cells were mutagenized with 3% ethyl methanesulfonate (EMS), 457 washed, and then spread onto YPD plates at 30°C to allow formation of single colonies. 458 Uniformly red colonies were first picked and restreaked on fresh YPD plates. The clones 459 remaining uniformly red after restreak were subsequently screened for those that are 5FOA-460 sensitive. The red 5FOA-sensitive colonies could also come from mutations that are synthetic 461 lethal with the ura3 or ade3 alleles, as pZW321 also carries wild type URA3 and ADE3. To 462 reduce the chance of isolating these undesired mutations, two modifications were made. First, an 463 additional copy of wild type FUR1 gene was integrated at the CAN1 gene locus of the starting 464 strain, because ura3 synthetic lethal mutations are most frequently found in FUR1 (Koren et al., 465 2003) . Second, the pAK12-1 plasmid carrying an ade3-pink allele was co-transformed with 466 pZW321 into ZOY261. Unlike wild type ADE3, the ade3-pink allele is partially functional, but 467 confers a pink (instead of red) colony color phenotype in ade2 ade3 background (Koren et al., 468 2003) . Therefore, in the presence of pAK12-1, the ade3 synthetic lethal mutants will not appear 469 as uniformly red colonies, but sectored with red and pink instead. To finally confirm that a strain contains a SMT3-Q56K-rescuable mutation, the strain was transformed with the pZW311 471 plasmid (CEN LEU2 SMT3-Q56K) , which should render the cells resistant to 5FOA after 472 transformation. 473 To identify the mutated gene, a wild type genomic DNA library (Jones et al., 2008) was 474 transformed into the candidate strains, and screened for 5FOA-resistant transformants. The 475 plasmids were then isolated and sequenced to identify the ends of the genomic DNA on the 476 plasmids. The mutated genes were identified by subcloning or by complementation experiments. 477 The genomic mutations were finally confirmed by PCR and sequencing. To summarize, ~80,000 478 colonies were initially screened, and 740 uniformly red ones were picked and restreaked. 105 479 clones remained red after restreak, among which 77 were 5FOA-sensitive. Finally, 25 of these 77 480 clones were confirmed to have mutations that can be suppressed by SMT3-Q56K (Table 1) . 481 482 Preparation of RNA from yeast cells. 483 RNA was prepared by the "Heat/Freeze" method as previously described with 484 modifications (Schmitt, Brown, & Trumpower, 1990) . Briefly, yeast cells were resuspended in 485 AE buffer (50 mM NaOAc pH 5.2, 10 mM EDTA, 1% SDS), mixed with equal volume of 486 phenol (pH 4.5), then incubated at 65°C for 4 min. The cell suspension was then frozen on dry 487 ice/ethanol bath and thawed at 37°C. After centrifugation at top speed, the RNA containing 488 upper layer was transferred to a new tube. RNA was extracted first with 489 phenol/chloroform/isoamyl alcohol (25:24:1), then with chloroform/isoamyl alcohol (24:1), and 490 finally precipitated with 100% ethanol containing 0.3M NaOAc (pH 5.2). The RNA pellet was 491 washed once with 70% ethanol and once with 100% ethanol, then dissolved in DEPC-treated 492 H2O at 50°C for 10 min. (Table S7 ) was used for reverse transcription. Second, primers were hybridized to RNA 498 by incubating the sample at 100°C for 5 min, followed by 65°C for 5 min, then held at 55°C. 499 Third, the RT enzyme mix was pre-warmed to 55°C before adding to the RNA/primer mix. 500 Fourth, reverse transcription was carried out at 55°C for 30 min, followed by 85°C for 5 min, and finally held at 4°C. The resulting DNA was diluted 10 times with H2O, and 2 l of the Table S6 . Data 506 are mean ± standard deviation calculated from 6 data points (two biological replicates and three 507 technical replicates), presented as relative amount compared to wild type. Yeast cultures were grown overnight at 30°C to log phase. Cell concentrations were then 529 adjusted to OD600 = 1. To start the chase, 50 mg/ml cycloheximide (Sigma, #C7698) was added 530 to a final concentration of 0.5 mg/ml. 1.5 ml culture was collected immediately as time point 0 in 531 an Eppendorf tube pre-loaded with 15 l 10% sodium azide. Cells were then washed with 1 ml water and frozen on dry ice. The remaining cultures were incubated at 30°C, and 1.5 ml samples 533 were collected every 30 min in the same way. Crude extracts were prepared by the post-alkaline 534 extraction method as described above. An anti-G6PDH (Sigma, #A9521) antibody was used to 535 detect G6PDH as loading control. Immunoblot analysis was performed using the Odyssey 536 infrared imaging system (LI-COR Biosciences). 
